|
World TB Day Media Video: Phase 3 MTBVAC TB Vaccine Study As rain clouds gather and soft showers fall onto the streets of Worcester, Chwayita Baxa quickly steps out of a branded South African Tuberculosis (TB) Vaccine Initiative (SATVI) vehicle. She’s carrying precious cargo in her arms and hurriedly makes her way to the nearest entrance of the Brewelskloof TB Hospital to move out of the rain. Under a thick blue and white sailor-themed fleece blanket is little Ivakele Azibula – napping sweetly in his mother’s arms.
|
|
2022 Heath Clark Lecture with Professor Thomas Scriba | LSHTM |
|
Press Conference: Announcement of Final M72/AS01E candidate vaccine results at the TB Science 2019, Hyderabad, India, November 2019, The Final results of the M72/AS01E candidate vaccine were announced at the TB Science 2019 conference.
|
TBSc02 TBScience: Prevent infection or prevent disease?
|
Plenary Session: Prevent infection or disease, TB Science 2019, Hyderabad, November 2019. Second plenary session of the TBScience 2019 preconference of the 50th Union World Conference on Lung Health which took place in #Hyderabad, #India. |
|
Virginie Rozot is a Research Officer at the South African Tuberculosis Vaccine Initiative, University of Cape Town (SATVI, UCT). Virginie conducted her PhD Research at the University of Lausanne, which she completed in 2013. She then began a Post-Doctoral Research fellowship at SATVI, UCT. Her research focuses on understanding Tuberculosis-specific immune responses associated with different stages of infection and disease progression, as well as novel TB vaccine responses. During her Post-Doc, part of her research utilised mass cytometry to understand immune kinetics associated with progression of TB disease. We were fortunate to conduct a special interview focusing on mass Cytometry and her experience using the first mass cytometer to cross the Southern Hemisphere [and is currently housed at SATVI, UCT, South Africa. |
|
Quantiferon Assay Instructional video- ENGLISH Quantiferon Assay Instructional video- FRENCH |
|
Panel discussion: H4:IC31 vaccine/BCG Revaccination, TB Vaccine Forum, New Delhi, February 2018, Panel discussion of the H4:IC31 Vaccination/BCG Revaccination Clinical Trial Results at the 5th Global Forum on TB Vaccines. |
|
Drama Performance Lienkie's Lungs/Beat TB, Hectic Nine 9, 2016 Hectic Nine 9 featured the Beat TB drama cast who performed "Lienkie's Lungs" on this SABC youth tv program. |
TB Awareness with Dr Michele and Vanessa
|
Televised interview, Dr Michele Tameris and TB affected person, Hectic Nine 9, 2016. Hectic Nine 9 featured the Beat TB drama cast who performed "Lienkie's Lungs" on this SABC youth tv program. |
|
Beat TB stories of engagement. Photovoice about Beat TB, an innovative project in Worcester, South Africa that used street theatre and taxi theatre to ignite conversation about TB. Click here. |
|
Fighting TB; South Africa's insidious epidemic, Oxford production, 2017 South Africa stands at the centre of a global TB epidemic devastating the health of millions and their communities. Oxford University is working with South African esearchers, health workers and community volunteers in the hunt for an urgently-needed new vaccine. Click here. |
|
Aeras, Wed Edge TV. |
Carina's Choice
|
Carina's Choice TB Awareness drama performance, 2012. Video Production of a Wellcome Trust funded project which took a dramatic production using high school learners as actors, to eight high schools in the Worcester area, reaching about 8 000 adolescents over 4 weeks in 2013. |
Fergus Walsh interviews TB vaccine developer Helen McShane at project site in South Africa
|
TB Timebomb. BBC Production Fergus Walsh gets exclusive access to a clinical trial site in South Africa (SATVI) testing a new TB vaccine. The vaccine was developed by a scientist from Oxford University, Helen McShane. |
|
"On developing vaccines", inaugural lecture of Professor Willem Hanekom, former Director of the South African Tuberculosis Vaccine Initiative (SATVI), speaks about his research in developing TB vaccines, the basis for his inaugural lecture, Vaccines to Prevent TB, delivered at the University of Cape Town on 4 May. |
Visit to TB research site by Emma Hurd, Sky News Emma Hurd of Sky News visits TB vaccine research site in the Western Cape province of South Africa, and gets the opportunity to speak to the University of Cape Town's Institute for Infectious Disease and Molecular Medicine (IDMM) Director, Professor Gregory Hussey and Dr Michele Tameris from SATVI at the project site. |
|
Jim Lehrer, TB documentary. As part of his documentary on tuberculosis (TB) in South Africa, Jim Lehrer visits Africa's largest dedicated TB vaccine research group in the Western Cape province. |
|
Craig David, Goodwill TB Ambassador visit to SATVI. People living with HIV are particularly vulnerable to tuberculosis. Not only are they much more likely to get it, they are also much more likely to die of the disease. One out of every four AIDS-related deaths is caused by tuberculosis. Last year, 400 000 people living with HIV died from tuberculosis. But these deaths are preventable: If people living with HIV test for tuberculosis they can get access to care and be cured. |
|
|